Investment analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the stock.
Retractable Technologies Trading Up 0.5 %
Shares of Retractable Technologies stock opened at $0.73 on Friday. Retractable Technologies has a fifty-two week low of $0.71 and a fifty-two week high of $1.34. The stock has a 50 day moving average of $0.84 and a 200 day moving average of $1.00. The firm has a market capitalization of $21.96 million, a price-to-earnings ratio of -2.82 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51.
Retractable Technologies (NYSE:RVP – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The company had revenue of $6.03 million during the quarter.
Insider Buying and Selling at Retractable Technologies
Institutional Trading of Retractable Technologies
An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors and hedge funds.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
See Also
- Five stocks we like better than Retractable Technologies
- Stock Dividend Cuts Happen Are You Ready?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Find and Profitably Trade Stocks at 52-Week Lows
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Differences Between Momentum Investing and Long Term Investing
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.